<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">875</article-id><article-id pub-id-type="doi">10.36691/RJA875</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">ASSOCIATION OF IL5, CCL26 AND CCL5 GENE POLYMORPHISMSWITH ATOPIC BRONCHIAL ASTHMA</article-title><trans-title-group xml:lang="ru"><trans-title>АССОЦИАЦИЯ ПОЛИМОРФНЫХ МАРКЕРОВГЕНОВ IL5, CCL26 И CCL5 С РАЗВИТИЕМАТОПИЧЕСКОЙ БРОНХИАЛЬНОЙ АСТМЫ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Voronko</surname><given-names>O E</given-names></name><name xml:lang="ru"><surname>Воронько</surname><given-names>О Е</given-names></name></name-alternatives><bio xml:lang="en"><p>Institute of Biomedical Chemistry of Russian Academy of Medical Sciences (IBMC RAMS)</p></bio><bio xml:lang="ru"><p>Учреждение Российской академии медицинских наук НИИ биомедицинской химииим. В.Н. Ореховича РАМН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dmitrieva-Zdorova</surname><given-names>E V</given-names></name><name xml:lang="ru"><surname>Дмитриева-Здорова</surname><given-names>Е В</given-names></name></name-alternatives><bio xml:lang="en"><p>Institute of Biomedical Chemistry of Russian Academy of Medical Sciences (IBMC RAMS)</p></bio><bio xml:lang="ru"><p>Учреждение Российской академии медицинских наук НИИ биомедицинской химииим. В.Н. Ореховича РАМН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Latysheva</surname><given-names>E A</given-names></name><name xml:lang="ru"><surname>Латышева</surname><given-names>Е А</given-names></name></name-alternatives><bio xml:lang="en"><p>State Scientific Centre «Institute of Immunology» FMBA</p></bio><bio xml:lang="ru"><p>ФГБУ «ГНЦ Институт иммунологии» ФМБА России</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aksenova</surname><given-names>M G</given-names></name><name xml:lang="ru"><surname>Аксенова</surname><given-names>М Г</given-names></name></name-alternatives><bio xml:lang="en"><p>Institute for Human Ecology and Environmental Health</p></bio><bio xml:lang="ru"><p>Государственное учреждение НИИ экологии человека и гигиены окружающей средыим. А.Н. Сысина РАМН</p></bio><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Storozhakov</surname><given-names>G I</given-names></name><name xml:lang="ru"><surname>Сторожаков</surname><given-names>Г И</given-names></name></name-alternatives><bio xml:lang="en"><p>Russian State Medical University</p></bio><bio xml:lang="ru"><p>Государственное образовательное учреждение высшего профессионального образования«Российский государственный медицинский университет Федерального агентствапо здравоохранению и социальному развитию»</p></bio><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bodoev</surname><given-names>N V</given-names></name><name xml:lang="ru"><surname>Арчаков</surname><given-names>Н В</given-names></name></name-alternatives><bio xml:lang="en"><p>Institute of Biomedical Chemistry of Russian Academy of Medical Sciences (IBMC RAMS)</p></bio><bio xml:lang="ru"><p>Учреждение Российской академии медицинских наук НИИ биомедицинской химииим. В.Н. Ореховича РАМН</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Biomedical Chemistry of Russian Academy of Medical Sciences (IBMC RAMS)</institution></aff><aff><institution xml:lang="ru">Учреждение Российской академии медицинских наук НИИ биомедицинской химииим. В.Н. Ореховича РАМН</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">State Scientific Centre «Institute of Immunology» FMBA</institution></aff><aff><institution xml:lang="ru">ФГБУ «ГНЦ Институт иммунологии» ФМБА России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Institute for Human Ecology and Environmental Health</institution></aff><aff><institution xml:lang="ru">Государственное учреждение НИИ экологии человека и гигиены окружающей средыим. А.Н. Сысина РАМН</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Russian State Medical University</institution></aff><aff><institution xml:lang="ru">Государственное образовательное учреждение высшего профессионального образования«Российский государственный медицинский университет Федерального агентствапо здравоохранению и социальному развитию»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2010-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2010</year></pub-date><volume>7</volume><issue>6</issue><issue-title xml:lang="en">NO6 (2010)</issue-title><issue-title xml:lang="ru">№6 (2010)</issue-title><fpage>20</fpage><lpage>24</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 1970, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 1970, Фармарус Принт Медиа</copyright-statement><copyright-year>1970</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2012-12-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/875">https://rusalljournal.ru/raj/article/view/875</self-uri><abstract xml:lang="en"><p>The purpose of the work. In order to investigate whether single nucleotide polymorphisms С(-703)Т in IL5
gene, T(+2497)G in CCL26 and A(-403)G in CCL5 gene contribute to atopic bronchial asthma development
we performed a comparative analysis of alleles and genotypes frequencies of these polymorphisms in Russian
patients from Moscow region.
Materials and methods. DNA samples from 283 patients with atopic bronchial asthma and 227 healthy donors
were genotyped.
Results. There were associations neither of С(-703)Т in IL5 gene, T(+2497)G in CCL26 and A(-403)G in CCL5
gene with asthma nor with asthma severity.
Conclusion. Therefore, we may conclude that genes responsible for activation and chemotaxis of eosinophils play
an insignificant role in susceptibility to development of atopic bronchial asthma, and probably may influence
indirectly specific processes that occur in asthma.-</p></abstract><trans-abstract xml:lang="ru"><p>Для того чтобы определить вклад полиморфных маркеров С(-703)Т гена IL5, T(+2497)G
гена CCL26 и A(-403)G гена CCL5 в развитие атопической бронхиальной астмы (АБА), проведен сравни-
тельный анализ распределения аллелей и генотипов данных маркеров у русских пациентов г. Москвы.
Материалы и методы. Сформированы две выборки, состоящие из 283 образцов ДНК больных АБА и 227
образцов ДНК здоровых людей (контрольная группа).
Результаты. Не установлено ассоциации маркеров С(-703)Т гена IL5, T(+2497)G гена CCL26 и A(-403)G
гена CCL5 с развитием АБА, а также с тяжестью течения заболевания.
Заключение. Таким образом, можно сделать предположение о том, что гены, ответственные за активацию и
направленную миграцию эозинофилов, не играют значительной роли в предрасположенности к развитию
АБА и, возможно, опосредованно могут влиять на специфические процессы, имеющие место при АБА.</p></trans-abstract><kwd-group xml:lang="en"><kwd>atopic bronchial asthma</kwd><kwd>MALDI-TOF mass spectrometry</kwd><kwd>T(+2497)G in CCL26 gene and A(-403)G in CCL5 gene</kwd><kwd>association</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>атопическая бронхиальная астма</kwd><kwd>масс-спектрометрия MALDI-TOF</kwd><kwd>полиморфные маркеры С(-703)Т гена IL5</kwd><kwd>T(+2497)G гена CCL26 и A(-403)G гена CCL5</kwd><kwd>ассоциация</kwd><kwd>polymorphic markers С(-703)Т in IL5 gene</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Ober C. Perspectives on the past decade of asthma genetics. J. Allergy Clin. Immunol. 2005, v. 116 (2), p. 274-278.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Wiesch D.G., Meyers D.A., Bleecker E.R. Genetics of asthma. J. Allergy Clin. Immunol. 1999, v. 104 (5), p. 895-901.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Marsh D.G., Neely J.D., Breazeale D.R. et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science. 1994, v. 264 (5162), p. 1152-1156.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Martinez F.D., Solomon S., Holberg C.J. et al. Linkage of circulating eosinophils to markers on chromosome 5q. Am. J. Respir. Crit. Care Med. 1998, v. 158(6), p. 1739-1744.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Rioux J.D., Stone V.A., Daly M.J. et al. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am. J. Hum. Genet. 1998, v. 63 (4), p. 1086-1094.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Фрейдин М.Б., Кобякова О.С., Огородова Л.М. и соавт. Наследуемость уровня общего интерлейкина-5 и полиморфизм C-703T гена IL5 у больных бронхиальной астмой. Бюлл. эксп. биол. мед. 2000, т. 129, прил. 1, с. 50-52.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Chae S.C., Park Y.R., Oh G.J. et al. The suggestive association of eotaxin-2 and eotaxin-3 gene polymorphisms in Korean population with allergic rhinitis. Immunogenetics. 2005, v. 56 (10), p. 760-764.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gao G.M., Wu J.M., Cui T.P., He Z.Q. The research on the correlation between eotaxin-3 gene polymorphisms and allergic asthma. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006, v. 23 (2), p. 169-172.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Сhae S.C., Lee Y.C., Park Y.R. et al. Analysis of the polymorphisms in eotaxin gene family and their a sociation with asthma, IgE, and eosinophil. Biochem. Biophys. Res. Commun. 2004, v. 320 (1), p. 131-137.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Nomura S., Ishii K., Kamitsuji Y. et al. Elevation of activated platelet-dependent chemokines in patients with antiCD20 monoclonal antibody (rituximab) treated non-odgkin's lymphoma. Clin. Appl. Thromb. Hemost. 2007, v. 13 (2), p. 206-212.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Nickel R.G., Casolaro V., Wahn U. et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J. Immunol. 2000, v. 164 (3), p. 1612-1616.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Fryer A.A., Bianco A., Hepple M. et al. Polymorphism at the glutathione Stransferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Am. J. Respir. Crit. Care Med. 2000, v. 161 (5), p. 1437-1442.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>AlAbdulhadi S.A., Helms P.J., Main M. et al. Preferential transmission and association of the 403 G &gt; A promoter RANTES polymorphism with atopic asthma. Genes Immun. 2005, v. 6 (1), p. 24-30.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Koshak E.A. Classification of asthma according to revised 2006 GINA: Evolution from severity to control. Ann. Thor. Med. 2007, v. 2, p. 45-46.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Wise C.A., Paris M., Morar B. et al. A standard protocol for single nucleotide primer extension in the human genome using matrix-assisted laser desorption/ionization time-offlight mass spectrometry. Rapid. Commun. Mass Spectrom. 2003, v. 17 (11), p. 1195-1202.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Hutchon D.J.R. Calculator for confidence intervals for odds ratio unmatched case control study. http://www.hutchon.net/ConfidOR.htm.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Kabesch M., Depner M., Dahmen I. et al. Polymorphisms in eosinophil pathway genes, asthma and atopy. Allergy. 2007, v. 62 (4), p. 423-428.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Hong S.J., Lee S.Y., Kim H.B. et al. IL-5 and thromboxane A2 receptor gene polymorphisms are associated with decreased pulmonary function in Korean children with atopic asthma. J. Allergy Clin. Immunol. 2005, v. 115 (4), p. 758-763.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Petkovic V., Moghini C., Paoletti S. et al. Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role. J. Biol. Chem. 2004, v. 279 (22), p. 23357-23363.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Moissidis I., Chinoy B., Yanamandra K. et al. Association of IL-13, RANTES, and leukotriene C4 synthase gene promoter polymorphisms with asthma and/or atopy in African Americans. Genet. Med. 2005, v. 7 (6), p. 406-410.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Muro M., Marin L., Torio A. et al. CCL5/RANTES chemokine gene promoter polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population. Int. J. Immunogenet. 2008, v. 35 (1), p. 19-23.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Stellato C., Beck L.A., Gorgone G.A. et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J. Immunol. 1995, v. 155 (1), p. 410-418.</mixed-citation></ref></ref-list></back></article>
